Key result
A new technology based on patient-specific computational modeling and simulation is being developed to provide personalized in-silico management for patients with atherosclerosis.
The development of patient-specific computational models offers a potential future tool for personalized in-silico management of atherosclerosis in vascular clinics.
Answers are grounded in this paper and cite their sources.
May support future personalized atherosclerosis management; leaves open prospective validation before clinical use.
The development of a new technology based on patient-specific modelling for personalised healthcare in the case of atherosclerosis is presented. Atherosclerosis is the main cause of death in the world and it has become a burden on clinical services as it manifests itself in many diverse forms, such as coronary artery disease, cerebrovascular disease/stroke and peripheral arterial disease. It is also a multifactorial, chronic and systemic process that lasts for a lifetime, putting enormous financial and clinical pressure on national health systems. In this Letter, the postulate is that the development of new technologies for healthcare using computer simulations can, in the future, be developed as in-silico management and support systems. These new technologies will be based on predictive models (including the integration of observations, theories and predictions across a range of temporal and spatial scales, scientific disciplines, key risk factors and anatomical sub-systems) combined with digital patient data and visualisation tools. Although the problem is extremely complex, a simulation workflow and an exemplar application of this type of technology for clinical use is presented, which is currently being developed by a multidisciplinary team following the requirements and constraints of the Vascular Service Unit at the University College Hospital, London.
No takes yet. Share an insight, caveat, or question.
Díaz‐Zuccarini et al. (2014) conducted a letter in Atherosclerosis. Patient-specific computational modelling and simulation was evaluated. A new technology based on patient-specific computational modeling and simulation is being developed to provide personalized in-silico management for patients with atherosclerosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: